ORLANDO, FL — In the AVERT trial of close to 600 patients who underwent coronary angiography and were at high risk of contrast-induced acute kidney injury (AKI), the studied device successfully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback